Early intervention with an immunotherapy-based drug combination may prevent progression of high-risk “smoldering” multiple myeloma to the full-blown disease, according to researchers from Dana-Farber Cancer Institute. +read more
.
Early treatment may prevent progression to multiple myeloma
Updated: Sep 28, 2018